Die Wertigkeit des sFlt-1/PlGF-Quotienten als Prädiktionsmarker bei
Schwangeren mit erhöhtem Präeklampsierisiko

Die Wertigkeit des sFlt-1/PlGF-Quotienten als Prädiktionsmarker bei Schwangeren mit erhöhtem Präeklampsierisiko

Einleitung: Die Dysbalance proangiogener (Placental Growth Factor = PlGF) und antiangiogener Faktoren (soluble fms-like tyrosine kinase 1 = sFlt-1) gilt heute als pathophysiologische Grundlage bei der Entstehung einer Präeklampsie (PE), eines HELLP-Syndroms (Haemolysis, Elevated Liver enzymes, Low P...

Full description

Bibliographic Details
Main Author:	Husse, Sorina
Other Authors:	Universitätsklinikum Leipzig, Abteilung für Geburtsmedizin
Format:	Doctoral Thesis
Language:	deu
Published:	Universitätsbibliothek Leipzig 2017
Subjects:	Präeklampsie sFlt-1/PlGF-Quotient Schwangerschaftsdiagnostik preeclampsia ddc:610
Online Access:	http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-224844 http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-224844 http://www.qucosa.de/fileadmin/data/qucosa/documents/22484/Dissertation_Husse_kurz.pdf.pdf

Similar Items

Die Wertigkeit des sFlt-1/PlGF-Quotienten als Prädiktionsmarker bei Schwangeren mit erhöhtem Präeklampsierisiko
by: Husse, Sorina Ines
Published: (2015)

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
by: Viktorija Tarasevičienė, et al.
Published: (2016-01-01)

Zusammenhang zwischen angiogenen Faktoren (sFlt-1/PlGF-Ratio) und klinischen Parametern des Schwangerschaftsausgangs bei manifesten hypertensiven Schwangerschaftserkrankungen
by: Tauscher, Anne
Published: (2013)

Prospektive Evaluierung von sFlt-1, PlGF und sEndoglin als prognostische Marker für die Entwicklung einer Präeklampsie bei Schwangerschaften mit uteriner Perfusionsstörung im 2. Trimenon
by: Schwarz, Friederike
Published: (2013)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
by: Szymon Kozłowski, et al.
Published: (2021-06-01)

Correlation of urine sFlt-1/PLGF ratio with abnormal trophoblast invasion and apoptosis in pregnant women with preeclampsia
by: Xi-Ping Hong, et al.
Published: (2018-07-01)

sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates
by: Jacek Witwicki, et al.
Published: (2021-08-01)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
by: Vivek Pant, et al.
Published: (2019-07-01)

Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration
by: Ignacio Herraiz, et al.
Published: (2015-08-01)

Study on sEng, VEGF, PLGF, and sFlt-1 levels, and umbilical artery blood flow change in the pregnant women with preeclampsia
by: Xia Liu
Published: (2016-04-01)

Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1/Placental Growth Factor (sFlt-1/PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia
by: Karoline Mayer-Pickel, et al.
Published: (2019-09-01)

Enhanced Serum Levels of sFlt1: Impact on Materno–Fetal CMV Transmission
by: Lukas Penka, et al.
Published: (2020-04-01)

Human Placental NADPH Oxidase Mediates sFlt-1 and PlGF Secretion in Early Pregnancy: Exploration of the TGF-β1/p38 MAPK Pathways
by: Isabelle Hernandez, et al.
Published: (2021-02-01)

Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis
by: Yousef Veisani, et al.
Published: (2019-01-01)

PlGF Immunological Impact during Pregnancy
by: Loredana Albonici, et al.
Published: (2020-11-01)

Multifaceted Role of the Placental Growth Factor (PlGF) in the Antitumor Immune Response and Cancer Progression
by: Loredana Albonici, et al.
Published: (2019-06-01)

Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36+ 0 weeks gestation
by: Lindsay Armstrong-Buisseret, et al.
Published: (2018-10-01)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
by: Kyle H. Moore, et al.
Published: (2020-06-01)

Potential use of sFlt-1 and pterin to predict the clinical outcome of cardiovascular disease.
by: Marks, Edward Charles Arthur
Published: (2015)

The umbilical cord, preeclampsia and the VEGF family
by: Olaya-C M, et al.
Published: (2018-11-01)

Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia
by: Pooneh Nikuei, et al.
Published: (2020-02-01)

Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
by: Anna Maria Nuzzo, et al.
Published: (2021-01-01)

Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells
by: Tadashi Sasagawa, et al.
Published: (2020-02-01)

Pro-angiogenic therapeutics for preeclampsia
by: Adrian C. Eddy, et al.
Published: (2018-08-01)

Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control Study
by: Evelyn A. Huhn, et al.
Published: (2018-11-01)

Trophoblast-Targeted Nanomedicine Modulates Placental sFLT1 for Preeclampsia Treatment
by: Lei Li, et al.
Published: (2020-02-01)

The sFlt-1/PlGF ratio as a predictor for poor pregnancy and neonatal outcomes
by: Yu-Shan Chang, et al.
Published: (2017-12-01)

ANGIOGENIC PROTEIN RATIO sFLT-1 / PlGF THE PREDICTIVE VALUE FOR PRE-ECLAMPSIA
by: Elena Mihalceanu, et al.
Published: (2013-06-01)

Activation of PAR-1/NADPH Oxidase/ROS Signaling Pathways is Crucial for the Thrombin-Induced sFlt-1 Production in Extravillous Trophoblasts: Possible Involvement in the Pathogenesis of Preeclampsia
by: Qi-tao Huang, et al.
Published: (2015-03-01)

Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia.
by: Evelyn Klein, et al.
Published: (2016-01-01)

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
by: Dietmar Schlembach, et al.
Published: (2018-08-01)

Analysis of Methyldopa Therapy on sFlt-1 Antiangiogenic Levels in Patients with Severe Preeclampsia
by: Teri Wina Herwati, et al.
Published: (2018-04-01)

Mechanisms of Hypoxia-Induced Neurovascular Remodeling in PlGF Knockout Mice
by: Freitas-Andrade, Moises
Published: (2012)

Mechanisms of Hypoxia-Induced Neurovascular Remodeling in PlGF Knockout Mice
by: Freitas-Andrade, Moises
Published: (2012)

Mechanisms of Hypoxia-Induced Neurovascular Remodeling in PlGF Knockout Mice
by: Freitas-Andrade, Moises
Published: (2012)

Mechanisms of Hypoxia-Induced Neurovascular Remodeling in PlGF Knockout Mice
by: Freitas-Andrade, Moises
Published: (2012)

Angiogenesefaktoren PlGF, sFlt-1 und sEng in unauffälligen Schwangerschaften und bei Präeklampsie
by: Thomas, Veronika
Published: (2012)

MZe786 Rescues Cardiac Mitochondrial Activity in High sFlt-1 and Low HO-1 Environment
by: Lissette Carolina Sanchez-Aranguren, et al.
Published: (2020-07-01)

High Level of Soluble FMS-Like Tyrosine Kinase-1 (sFlt-1) Serum in Pregnancy as a Risk Factor of Preeclampsia
by: I Gede Mega Putra, et al.
Published: (2016-07-01)

Differences in levelFms-Like Tyrosine Kinase-1 (sFlt-1), soluble Endoglin (s-Eng), and Placental Growth Factor (PIGF) between Early Onset Preeclampsia and Late Onset Preeclampsia
by: Lita Nafratilova, et al.
Published: (2018-10-01)